Phase II Study of Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia.
Latest Information Update: 08 Nov 2021
At a glance
- Drugs Imatinib (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- Sponsors Novartis
Most Recent Events
- 12 Mar 2011 New trial record